-
Offit profited from the creation of the rotavirus vaccine, but does not get ongoing money from vaccine manufacturers for speaking, consulting, research, or as royalties.
FORBES: Don't Be Frightened By Japan's Vaccine Scare
-
From July, all babies aged between two and four months will be offered a two-dose oral vaccine against the rotavirus, a highly infectious diarrhoea and vomiting bug.
BBC: Shingles vaccine to be routine for people in their 70s
-
The FDA last March asked pediatricians to stop administering GlaxoSmithKline's Rotarix, a vaccine that prevents rotavirus infection, a diarrheal illness that commonly affects infants and children and that can cause severe dehydration.
FORBES: Magazine Article
-
The company will work with regulatory authorities to continue to provide the vaccine to help protect children from rotavirus disease.
FORBES: GlaxoSmithKline On FDA's Rotavirus Vaccine Concerns
-
Experts say accelerating introduction of the vaccine in Africa and Asia - where the rotavirus has most impact - must be made a top priority.
BBC: Move to cut child diarrhoea death
-
In the US, it is claimed rotavirus-related hospital admissions have fallen by as much as 86% due to the vaccine.
BBC: Babies born from May to be offered rotavirus vaccine
-
The results of a trial of another oral vaccine called Rotarix, developed by GlaxoSmithKline, showed it was effective against the most common strain of rotavirus and able to prevent 85% of severe cases.
BBC: NEWS | Health | Diarrhoea vaccine tests 'hopeful'